PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech’s Covid vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech’s COVID-19 vaccine. “We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We’ve 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” said Dr OP Kalra, vice-chancellor, PGI Rohtak. Kalra also informed that in the phase-2 trial, they have recruited volunteers who have controlled diabetes and high blood pressure. Watch the full video for more details.
.
.
Connect with Hindustan Times
Press the bell icon on YouTube for all the latest updates from Hindustan Times
Like us on Facebook: facebook.com/hindustantimes
Tweet us on Twitter: twitter.com/httweets

Source : Hindustan Times

Disclaimer: This NEWS post has been auto-published from an media agency feed without any modifications to the text. It has not been reviewed by an editor.

Leave a Reply

Your email address will not be published. Required fields are marked *